Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity- enhancing factor on the development of human immunodeficiency virus 1

doi:10.1084/jem.180.1.359

This Article

	Full Text (PDF, 586K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Newman, G. W.
	Articles by Silberstein, D. S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Newman, G. W.
	Articles by Silberstein, D. S.


Social Bookmarking

	What's this?

ARTICLES

Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity- enhancing factor on the development of human immunodeficiency virus 1

GW Newman, MK Balcewicz-Sablinska, JR Guarnaccia, HG Remold and DS Silberstein
Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Exogenous recombinant human thioredoxin (rTRX, > or = 500 nM), a dithiol reductase enzyme, inhibited the expression of human immunodeficiency virus (HIV) 1BaL in human macrophages (M phi) by 71% (range, 26-100%), as evaluated by p24 antigen production and the integration of provirus at 14 d after infection. The stoichiometric reducing agent N-acetylcysteine (NAC) also inhibited HIV production, but to a lesser degree, and only at 30,000-fold higher concentrations. Exogenous rTRX is cleaved by M phi to generate the inflammatory cytokine, eosinophil cytotoxicity-enhancing factor (ECEF). In contrast to rTRX, rECEF (concentrations from 50 pM to 2 microM) enhanced the production of HIV by 67% (range, 33-92%). Thus, whereas TRX is a potent inhibitor of the expression of HIV in human M phi, cleavage of TRX to ECEF creates a mediator with the opposite effect. TRX also inhibited the expression of integrated provirus in the chronically infected OM 10.1 cell line, showing that it can act at a step subsequent to viral infection and integration.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Kalantari, P., Narayan, V., Natarajan, S. K., Muralidhar, K., Gandhi, U. H., Vunta, H., Henderson, A. J., Prabhu, K. S. (2008). Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages. J. Biol. Chem. 283: 33183-33190 [Abstract] [Full Text]
Pekkari, K., Goodarzi, M. T., Scheynius, A., Holmgren, A., Avila-Carino, J. (2005). Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK. Blood 105: 1598-1605 [Abstract] [Full Text]
Lopata, A., Sibson, M.C., Enders, A.C., Bloomfield, K.L., Gregory, M.S., Trapani, G.D., Perkins, A.V., Tonissen, K.F., Clarke, F.M. (2001). Expression and localization of thioredoxin during early implantation in the marmoset monkey. Mol Hum Reprod 7: 1159-1165 [Abstract] [Full Text]
Pekkari, K., Avila-Carino, J., Bengtsson, A., Gurunath, R., Scheynius, A., Holmgren, A. (2001). Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 97: 3184-3190 [Abstract] [Full Text]
Junn, E., Han, S. H., Im, J. Y., Yang, Y., Cho, E. W., Um, H. D., Kim, D. K., Lee, K. W., Han, P. L., Rhee, S. G., Choi, I. (2000). Vitamin D3 Up-Regulated Protein 1 Mediates Oxidative Stress Via Suppressing the Thioredoxin Function. J. Immunol. 164: 6287-6295 [Abstract] [Full Text]
Lee, K.-K., Murakawa, M., Takahashi, S., Tsubuki, S., Kawashima, S.-i., Sakamaki, K., Yonehara, S. (1998). Purification, Molecular Cloning, and Characterization of TRP32, a Novel Thioredoxin-related Mammalian Protein of 32�kDa. J. Biol. Chem. 273: 19160-19166 [Abstract] [Full Text]
Spyrou, G., Enmark, E., Miranda-Vizuete, A., Gustafsson, J.-A. (1997). Cloning and Expression of a Novel Mammalian Thioredoxin. J. Biol. Chem. 272: 2936-2941 [Abstract] [Full Text]
Pekkari, K., Gurunath, R., Arner, E. S. J., Holmgren, A. (2000). Truncated Thioredoxin Is a Mitogenic Cytokine for Resting Human Peripheral Blood Mononuclear Cells and Is Present in Human Plasma. J. Biol. Chem. 275: 37474-37480 [Abstract] [Full Text]